388 related articles for article (PubMed ID: 29803274)
1. Evolving Complexity in Hemophilia Management.
Croteau SE
Pediatr Clin North Am; 2018 Jun; 65(3):407-425. PubMed ID: 29803274
[TBL] [Abstract][Full Text] [Related]
2. The past and future of haemophilia: diagnosis, treatments, and its complications.
Peyvandi F; Garagiola I; Young G
Lancet; 2016 Jul; 388(10040):187-97. PubMed ID: 26897598
[TBL] [Abstract][Full Text] [Related]
3. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
4. 2017 Clinical trials update: Innovations in hemophilia therapy.
Hartmann J; Croteau SE
Am J Hematol; 2016 Dec; 91(12):1252-1260. PubMed ID: 27563744
[TBL] [Abstract][Full Text] [Related]
5. The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing.
Mancuso ME; Mahlangu JN; Pipe SW
Lancet; 2021 Feb; 397(10274):630-640. PubMed ID: 33460559
[TBL] [Abstract][Full Text] [Related]
6. New therapies for hemophilia.
Weyand AC; Pipe SW
Blood; 2019 Jan; 133(5):389-398. PubMed ID: 30559264
[TBL] [Abstract][Full Text] [Related]
7. Management of hemophilia in developing countries.
Kashyap R; Choudhry VP
Indian J Pediatr; 2001 Feb; 68(2):151-7. PubMed ID: 11284184
[TBL] [Abstract][Full Text] [Related]
8. Advances in the care and treatment of children with hemophilia.
Manco-Johnson MJ
Adv Pediatr; 2010; 57(1):287-94. PubMed ID: 21056743
[No Abstract] [Full Text] [Related]
9. Current concepts in diagnosis and management of hemophilia.
Aledort LM
Hosp Pract (Off Ed); 1982 Oct; 17(10):77-84, 89-92. PubMed ID: 6811410
[No Abstract] [Full Text] [Related]
10. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
[TBL] [Abstract][Full Text] [Related]
11. Specific therapy in hemophilia.
Hutaff LW
N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809
[No Abstract] [Full Text] [Related]
12. How do we optimally utilize factor concentrates in persons with hemophilia?
Lim MY
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):206-214. PubMed ID: 34889393
[TBL] [Abstract][Full Text] [Related]
13. Continuous prophylaxis with recombinant factor IX Fc fusion protein and conventional recombinant factor IX products: comparisons of efficacy and weekly factor consumption.
Iorio A; Krishnan S; Myrén KJ; Lethagen S; McCormick N; Yermakov S; Karner P
J Med Econ; 2017 Apr; 20(4):337-344. PubMed ID: 27885871
[TBL] [Abstract][Full Text] [Related]
14. Pioneering therapeutic proteins in hemophilia care through innovative technologies.
Pabinger-Fasching I; Négrier C
Thromb Res; 2016 May; 141 Suppl 3():S1. PubMed ID: 27288062
[No Abstract] [Full Text] [Related]
15. The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges.
Trinchero A; Sholzberg M; Matino D
Hamostaseologie; 2020 Aug; 40(3):311-321. PubMed ID: 32726826
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and management of hemophilia].
Tokugawa T
Rinsho Ketsueki; 2020; 61(9):1338-1348. PubMed ID: 33162534
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in developing specific therapies for haemophilia.
Ling G; Nathwani AC; Tuddenham EGD
Br J Haematol; 2018 Apr; 181(2):161-172. PubMed ID: 29359795
[TBL] [Abstract][Full Text] [Related]
18. [New viewpoints in the treatment of hemophilia].
Göbel U
Dtsch Med Wochenschr; 1973 Sep; 98(39):1814-6. PubMed ID: 4583442
[No Abstract] [Full Text] [Related]
19. Hemophilia.
Kashyap R; Choudhry VP
Indian Pediatr; 2000 Jan; 37(1):45-53. PubMed ID: 10745388
[No Abstract] [Full Text] [Related]
20. Hemophilia.
Schick PK
Med Clin North Am; 1973 Jul; 57(4):1095-106. PubMed ID: 4576149
[No Abstract] [Full Text] [Related]
[Next] [New Search]
